Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips These trending Reddit stocks have considerable growth catalysts in motion, offering healthy upside potential in May and beyond. AdvisorShares Pure U.S. Cannabis ETF ( MSOS ): This leading cannabis ETF offers exposure...
Clinical stage pharma company Citius Pharmaceuticals (NASDAQ:CTXR) announced on Friday that it has selected the clinical research organization (CRO), Biorasi, to assist in the expansion of its Phase 3 Mino-Lok trial to additional sites outside the U.S. The pivotal trial is an open-label rando...
Citius Pharmaceuticals to Accelerate Phase 3 Mino-Lok Trial by Expanding Trial Sites Internationally PR Newswire Additional sites to support trial completion by end of 2022 CRANFORD, N.J. , May 6, 2022 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Ci...
Citius Pharmaceuticals, Inc. Provides Business Update, Highlights Upcoming Milestones PR Newswire CRANFORD, N.J. , May 3, 2022 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical com...
Citius Pharmaceuticals (CTXR) formal corporate presentation from NobleCon18 - Noble Capital Markets 18th Annual Small & Microcap Investor Conference - April 2022. Read More >>
Citius Pharmaceuticals Enrolls First Patient in Phase 2b Study of Halo-Lido for the Prescription Treatment of Hemorrhoids PR Newswire Primary endpoint is the reduction in hemorrhoidal symptoms CRANFORD, N.J. , April 26, 2022 /PRNewswire/ -- Citius...
Clarus Therapeutics (CRXT) +18%. AlloVir (ALVR) +18% on FDA regenerative medicine tag for posoleucel to prevent 6 viruses in cell transplant patients. Westwater Resources (WWR) +15% and Alabama Graphite Products break ground on Kellyton processing plant. IceCure Medical (...
Citius Pharmaceuticals to Present at the NobleCon18 Investor Conference on April 20, 2022 PR Newswire CRANFORD, N.J. , April 14, 2022 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical c...
Citius Pharmaceuticals (NASDAQ:CTXR) on Wednesday announced a management realignment that the company says will help it focus its resources on advancing the commercialization of its I/ONTAK and Mino-Lok product candidates as their phase 3 programs near completion. Citius co-founder and curren...
Citius Pharmaceuticals is a late-stage biopharma focused on critical care products. Preventing shareholder dilution. Resumption of clinical trials after COVID-19. For further details see: Critical Care Biopharma - Citius Pharmaceuticals
News, Short Squeeze, Breakout and More Instantly...
Citius Pharmaceuticals Inc. Company Name:
CTXR Stock Symbol:
NASDAQ Market:
Citius Pharmaceuticals Inc. Website:
2024-07-18 10:20:00 ET July 18, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at biotech/biopharma stocks, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:CTXR ), a late-stage biopharmaceutical compa...
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - July 18, 2024) - Investorideas.com , a go-to investing platform releases the second of a two-part series looking at biotech/biopharma stocks, featuring Citius Pharmaceuticals, Inc. (NASDAQ: CTXR), a late-stage biopharmaceutical c...
2024-07-17 10:10:00 ET July 17, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the first of a two-part series looking at biotech/biopharma stocks, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:CTXR ), a late-stage biopharmaceutical compan...